As figure skating superstar Camilla Balieva's doping allegations turned out to be true, her participation in the Beijing Winter Olympics became uncertain.
She will decide whether Baliyeva can compete in the women's figure skating singles event at an emergency hearing by the Court of Arbitration for Sports, soon to be held.
The International Olympic Committee officially announced in a daily briefing that Balieva tested positive for her drug test.
According to AP, Reuters, and AFP news, trimetazidine, a banned drug, was detected in a sample of Balieva collected at the Russian Championships held in St. Petersburg, Russia on December 25 last year.
Trimetazidine can also be used as a stimulant to help improve endurance by increasing blood flow as a treatment for angina.
The Russian Anti-Doping Agency issued a provisional ban on Balieva on the 8th after confirming her positive test result.
However, Balieva objected to this and appealed, and the Russian Anti-Doping Agency, after a meeting, withdrew the discipline and allowed Balieva to continue playing at the Beijing Winter Olympics.
The International Olympic Committee and the International Prosecutors' Office objected to the Russian Anti-Doping Agency's decision.
The International Prosecutor's Office filed a complaint with the Court of Arbitration for Sports, arguing that the withdrawal of her disciplinary action against her Baliyeva was unreasonable.
She is asking the Sports Arbitration Tribunal to hold an emergency hearing so that the women's singles match starts on the 15th, so it can be concluded before that.
If the Court of Arbitration for Sport favors the International Olympic Committee, Balieva will not be able to compete in the singles event.
It was also up to the Court of Arbitration for Sport to deprive her of her gold medal in the figure skating team event.